A consolidated view of market events, assembled from diverse sources.
Saatvik Green Energy has secured a significant ₹1,041.63 crore order from SECI for solar PV module supply, with execution scheduled over 15 months until December 2027. This adds to the company's growing order book of 6.35 GW as of June 2026, though recent financial performance shows a 95.45% decline in Q1 net profit to ₹5.3 crore due to weak revenues.
Sudarshan Pharma Industries announced that its proposal to acquire a 9.50% equity stake in US-based MedTherapy Biotechnology Inc. remains under due diligence, with confirmation and board resolution pending. The acquisition is part of the company's strategy to enter the US market and access MedTherapy's existing customer base and distribution network.
Mumbai-based Blue Star Ltd announced that W.J. Towell & Co LLC has filed an appeal with the Dubai Court of Appeal seeking to annul an arbitration award that dismissed all claims against the company. The appeal relates to a 2015 shareholders' agreement dispute, while Blue Star continues to face margin pressure from rising raw material costs despite price increases.
Dr Reddy's Laboratories has launched NIVORZ, a biosimilar to Bristol Myers Squibb's nivolumab (Opdivo) cancer drug, in India following DCGI approval. The company developed and manufactured the drug entirely in-house at its Hyderabad facility, with clinical trials involving 288 patients showing comparable efficacy to the reference product across 12 cancer indications.
State-run BHEL has formed a 50:50 joint venture with Titagarh Rail Systems to provide 35-year maintenance services for Vande Bharat sleeper trainsets. The JVC will be incorporated with ₹50 lakh initial capital and equal ownership stakes from both companies, with operations expected to commence from September 15, 2026.
The Delhi High Court's Intellectual Property Division is examining whether a dispute between Gillette India and Bombay Shaving Company (BSC) over BSC's Switch4 advertising campaign falls within its jurisdiction. Justice Jyoti Singh questioned whether mere disparagement of a brand without direct intellectual property infringement should be heard by the IPD, while expressing concerns about repeated advertising disputes between the companies.
Bharat Heavy Electricals Ltd (BHEL) has approved a ₹65 crore equity investment in its joint venture NTPC BHEL Power Projects Private Limited (NBPPL) to support operations and settle urgent liabilities. The 50:50 joint venture, incorporated in April 2008, focuses on EPC contracts for power plants and equipment manufacturing, with turnover growing from ₹18.19 crore in 2023-24 to ₹3.48 crore in 2024-25.
Maruti Suzuki India has received an ESG score upgrade to 68 (Strong rating category) for FY 2025-26, improving from 63 in the previous year. The upgrade was provided by SEBI-registered Crisil ESG Ratings & Analytics, with the company's core ESG score also improving to 64 from 57, demonstrating enhanced sustainability and governance practices.
Orkla India, maker of MTR Foods, is positioning itself to become one of India's fastest-growing multi-category food companies over the next five years through premiumisation, health and wellness offerings, and rapid expansion of quick commerce. The company is actively looking to consolidate the fragmented Indian spices industry through acquisitions while capitalising on evolving consumer preferences towards healthier food options and premium products.
Brickwork Ratings has assigned a 'BBB/Stable' rating to Anlon Healthcare Limited's bank loan facilities worth ₹23.60 crore, reflecting the company's strong pharmaceutical sector fundamentals and improved financial performance. The rating is supported by the company's 87.61% profit growth in Q1 FY27, projected ₹270 crore revenue for FY2027, and robust liquidity position, though it faces constraints from intense competition and regulatory compliance risks.